Patterns of gene expression and copy-number alterations in von-hippel lindau disease-associated and sporadic clear cell carcinoma of the kidney.
about
Wnt signaling pathways in urological cancers: past decades and still growingNIRF constitutes a nodal point in the cell cycle network and is a candidate tumor suppressorPatient-derived tumour xenografts as models for oncology drug developmentState of the science: an update on renal cell carcinomaHIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progressionEffects on survival of BAP1 and PBRM1 mutations in sporadic clear-cell renal-cell carcinoma: a retrospective analysis with independent validation.The role of aberrant VHL/HIF pathway elements in predicting clinical outcome to pazopanib therapy in patients with metastatic clear-cell renal cell carcinoma.Lipid Droplets: A Key Cellular Organelle Associated with Cancer Cell Survival under Normoxia and HypoxiaDistinct lymphocyte antigens 6 (Ly6) family members Ly6D, Ly6E, Ly6K and Ly6H drive tumorigenesis and clinical outcomeIntegrative genome-wide gene expression profiling of clear cell renal cell carcinoma in Czech Republic and in the United StatesDevelopment of synchronous VHL syndrome tumors reveals contingencies and constraints to tumor evolutionGenomic copy number alterations in clear cell renal carcinoma: associations with case characteristics and mechanisms of VHL gene inactivationCOEXPEDIA: exploring biomedical hypotheses via co-expressions associated with medical subject headings (MeSH)AHNAK2 is a Novel Prognostic Marker and Oncogenic Protein for Clear Cell Renal Cell Carcinoma.Transcriptome-based analysis of kidney gene expression changes associated with diabetes in OVE26 mice, in the presence and absence of losartan treatmentSignificance of chromosome 9p status in renal cell carcinoma: a systematic review and quality of the reported studies.Validation of housekeeping gene and impact on normalized gene expression in clear cell renal cell carcinoma: critical reassessment of YBX3/ZONAB/CSDA expressionMolecular genetics of clear-cell renal cell carcinomaPrimary cell cultures from human renal cortex and renal-cell carcinoma evidence a differential expression of two spliced isoforms of Annexin A3.Detecting independent and recurrent copy number aberrations using interval graphs.Comparative gene expression profiling analysis of urothelial carcinoma of the renal pelvis and bladderBirt-Hogg-Dubé renal tumors are genetically distinct from other renal neoplasias and are associated with up-regulation of mitochondrial gene expression.Integrated profiling of microRNAs and mRNAs: microRNAs located on Xq27.3 associate with clear cell renal cell carcinoma.MYC activation cooperates with Vhl and Ink4a/Arf loss to induce clear cell renal cell carcinoma.Differential expression of CHL1 gene during development of major human cancers.Systematic Analysis of the Expression of the Mitochondrial ATP Synthase (Complex V) Subunits in Clear Cell Renal Cell Carcinoma.Renal cell carcinoma primary cultures maintain genomic and phenotypic profile of parental tumor tissues.Genomic Analysis as the First Step toward Personalized Treatment in Renal Cell CarcinomaRecurrenceOnline: an online analysis tool to determine breast cancer recurrence and hormone receptor status using microarray data.Renal cell carcinoma: where will the state-of-the-art lead us?Recent updates in renal cell carcinomaA Comprehensive Study of Progressive Cytogenetic Alterations in Clear Cell Renal Cell Carcinoma and a New Model for ccRCC Tumorigenesis and ProgressionDiscovering tumor suppressor genes through genome-wide copy number analysis.Combined classical cytogenetics and microarray-based genomic copy number analysis reveal frequent 3;5 rearrangements in clear cell renal cell carcinomaBAP1 loss defines a new class of renal cell carcinoma.Chromosome 9p deletion in clear cell renal cell carcinoma predicts recurrence and survival following surgery.Integrative genome-wide expression profiling identifies three distinct molecular subgroups of renal cell carcinoma with different patient outcomeLoss of heterozygosity and SOSTDC1 in adult and pediatric renal tumors.An integrated approach to uncover drivers of cancer.FoxOs enforce a progression checkpoint to constrain mTORC1-activated renal tumorigenesis.
P2860
Q54954870-D5F07685-CCE9-4EF5-A1AF-3B81706ED359Q54954872-50B3FDE9-BC7D-470A-8484-9F53321F1397Q54954873-B281492A-3AE3-4E45-BE15-E9900A89757AQ54954874-C641A9B9-9936-4570-844E-A4F6BC862D23Q54954875-9A4A4F80-5F50-4904-8988-05241E9FEFFDQ54954876-37333A5A-4683-4CA7-A4C2-A83BA448599BQ54954877-BE0F9578-E119-4BC1-A9AB-3B8A4233715A
P1343
Q21245761-11F7C354-3D26-4B5B-B69E-4109F9A46D7BQ24338837-B8E3623A-5871-4970-A33D-D0BCBB271DD6Q24604068-FFC3D592-1DE3-4C8C-BED6-CD0AC8ADCB0BQ24630685-4D1C7E6F-6E96-469D-9C55-FB1F19F00ACBQ27025886-3394FE64-99D4-42E1-B2A8-271E06A987C7Q27852038-A8C32FAF-C6F9-4D4D-BE55-42817AD70A2DQ27852466-BFBE54E9-B4FD-40F4-9B98-C15E4A9BCA8DQ28078259-046A5016-EBE2-4B30-8102-0EBDF6D6364FQ28273187-2D158245-C42F-45E2-9E5E-E7B67E70F2BBQ28487676-34ADF32F-C0DF-4D1F-A2E7-0E3C1F19D2AFQ28655705-33E386AA-A6EB-4F70-BBBB-D9523723E578Q28728573-4111FCC6-E63E-4A88-9B62-A91ACEABDC51Q28818101-FD3EC033-9DB0-4755-9903-EC3CADF594ABQ33588156-D12FFEBD-12DB-467D-BC85-635F112F2B12Q33610151-331F0C97-E203-4ECC-A624-B007AAFEF754Q33616134-FF4AB191-0E7D-48D0-BB65-6F2BA8A59EBCQ33712289-2508A8D4-84B1-4C04-9C28-9E3E896EE867Q33729097-2FADEFDA-F165-41DB-B345-3B29340060C4Q33745126-A8ED89ED-00F6-4EDA-AB29-273484B31EA7Q33760431-45AFE040-588E-4B1A-801E-B7988EE3D52CQ33772260-EA624FC7-C9C3-4FEE-8FEB-F6F120E21E2EQ33772820-84B7FD8F-500E-4161-9BAE-85856477256AQ33799049-6142960F-B7A6-470E-BD61-91E6927CC8BDQ33804675-7BB3CCC4-749D-436D-B52A-FA747682558FQ33847826-6A7A2666-7C3D-4576-842E-D485DE084D60Q33869708-AFC8832A-A03A-47ED-8845-A6533B11ECE6Q33931096-1B235500-E4E9-4890-869A-A273579B4353Q33947929-C786FE18-C396-43FF-88FE-9A803D8949C4Q33966102-7941F4BC-A9DB-4976-B471-6DBFC06E83C6Q34003335-CF65DFD7-140F-4C0B-990A-45ECEA179CD4Q34003369-C273FF69-1813-4BD7-86D1-FBFC20A28BABQ34018955-6192DD30-B091-48DE-98FE-F1920428312DQ34152841-CF1B05DA-FCCD-4C7C-BCBE-29333F377EA8Q34193780-502BFC38-A0B6-4758-979B-DDA4915AA1F3Q34280223-D1319FF7-4C5E-419D-B969-8A076E35F6AAQ34283721-63E32BDA-FE83-4C92-9356-ABE03137FA75Q34348285-EDB1011A-E299-477F-8748-F761077073CEQ34408171-175C9EE0-D5C0-4A75-A69A-EC25132DCE6EQ34453995-FBFDD3EB-D9EE-44F5-ADFD-B619725F664AQ34504786-B6DCE215-761B-4DCF-9AB8-8112FC868FD5
P2860
Patterns of gene expression and copy-number alterations in von-hippel lindau disease-associated and sporadic clear cell carcinoma of the kidney.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Patterns of gene expression an ...... cell carcinoma of the kidney.
@en
Patterns of gene expression an ...... cell carcinoma of the kidney.
@nl
type
label
Patterns of gene expression an ...... cell carcinoma of the kidney.
@en
Patterns of gene expression an ...... cell carcinoma of the kidney.
@nl
prefLabel
Patterns of gene expression an ...... cell carcinoma of the kidney.
@en
Patterns of gene expression an ...... cell carcinoma of the kidney.
@nl
P2093
P2860
P4510
P50
P1433
P1476
Patterns of gene expression an ...... cell carcinoma of the kidney.
@en
P2093
Apryle Seeley
Arianna Di Napoli
David Linhart
Holger Moch
Jean-Philippe Brunet
Kirsten D Mertz
Maira M Pires
Rameen Beroukhim
Robert A Worrell
Sabina Signoretti
P2860
P304
P356
10.1158/0008-5472.CAN-09-0146
P407
P577
2009-06-01T00:00:00Z